SCHEMBL19233196

SCHEMBL19233196

CNc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BRAF P15056 17/20 0.58
KDR P35968 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20725644 0.89 BRAF (0.56) BRAFKDR
SCHEMBL14964588 0.87 BRAF (0.77) BRAF
SCHEMBL20577794 0.86 BRAF (0.57) BRAFKDR
SCHEMBL15304986 0.86 KDR (0.64) BRAFKDR
SCHEMBL19233398 0.86 PIK3CA (0.46) BRAFKDR
SCHEMBL9912806 0.86 BRAF (0.52) BRAFKDR
SCHEMBL14964675 0.86 BRAF (0.69) BRAF
SCHEMBL20725632 0.85 BRAF (0.55) BRAFKDR
SCHEMBL19233241 0.85 KDR (0.78) BRAFKDR
SCHEMBL9912802 0.85 BRAF (0.78) BRAFKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017135589-A9 PYRIDINE DERIVATIVE INHIBITING RAF KINASE AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR, METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF 삼진제약주식회사 2017-10-19 WO disclosed
WO-2017135589-A1 PYRIDINE DERIVATIVE INHIBITING RAF KINASE AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR, METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF 삼진제약주식회사 2017-08-10 WO disclosed